MedTrace Logo

Idiopathic Chronic Thrombocytopenia of Undetermined Significance : Pathogenesis and Biomarker

NCT04003220 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 80

Last updated 2022-11-28

No results posted yet for this study

Summary

It is a translational research study with mechanistical objectives and including biological samples of patients with thrombocytopenia

Conditions

Interventions

PROCEDURE

blood sample

The extra samples will be taken Blood sampling

PROCEDURE

Bone marrow sample

This bone marrow sampling will be performed for 10 patients with ICTUS, and 10 controls

Sponsors & Collaborators

  • Institut National de la Santé Et de la Recherche Médicale, France

    collaborator OTHER_GOV

  • University Hospital, Bordeaux

    lead OTHER

Principal Investigators

  • JAMES, MD, PhD · University Hospital, Bordeaux

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-09-07
Primary Completion
2023-09-07
Completion
2023-09-07

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04003220 on ClinicalTrials.gov